Online meditation training for people with multiple sclerosis: A randomized controlled trial

Multiple Sclerosis : Clinical and Laboratory Research
Cesare CavaleraFrancesco Pagnini

Abstract

Multiple sclerosis (MS) has a relevant impact on quality of life (QOL) and is associated with increased risks of psychological morbidity. Mindfulness-based interventions (MBIs) are among the most studied interventions, although few well-conducted studies have tested them in this field. Furthermore, the participation in typical MBIs may be impaired by time and logistics. We aimed to test the efficacy of an online MBI to improve QOL, psychological well-being, sleep, and fatigue. We conducted a randomized controlled trial, in which 139 participants were randomly assigned to an MS-specific online mindfulness meditation intervention or to a psychoeducational (active control) group. Participants were assessed for QOL, depression, anxiety, sleep problems, and fatigue, at three different times: at recruitment, after 2 months, and after 6 months. In comparison to the control group, the experimental subjects reported higher QOL and lower depression, anxiety, and sleep problems at the end of intervention. However, after 6 months these group differences were no longer significant. An online MBI could be an effective psychological treatment for the promotion of well-being in MS in short-term. However, the lack of lasting effects requires th...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Jul 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·A SolariP Mosconi
Apr 22, 2003·Journal of Personality and Social Psychology·Kirk Warren Brown, Richard M Ryan
Jul 17, 2004·Journal of Psychosomatic Research·Paul GrossmanHarald Walach
Mar 1, 2005·Multiple Sclerosis : Clinical and Laboratory Research·D KosJ Jansa
Dec 24, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Laura MendozziLuigi Pugnetti
Jan 8, 2014·JAMA Internal Medicine·Madhav GoyalJennifer A Haythornthwaite
Jan 21, 2014·BMC Neurology·Robert SimpsonStewart Mercer
Aug 12, 2014·Neurology Research International·Adam B LevinGeorge A Jelinek
Jan 15, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Ruth Ann MarrieNadia Reider
Mar 15, 2015·Multiple Sclerosis : Clinical and Laboratory Research·A BogosianR Moss-Morris
Sep 12, 2015·The Lancet. Psychiatry·Francesco Pagnini, Deborah Philips
Feb 10, 2016·Multiple Sclerosis and Related Disorders·K M FiestUNKNOWN CIHR Team Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease
May 31, 2016·British Journal of Health Psychology·Angeliki BogosianRona Moss-Morris

❮ Previous
Next ❯

Citations

Feb 1, 2019·Current Treatment Options in Neurology·Giorgos K SakkasMauro Manconi
Jun 9, 2020·Informatics for Health & Social Care·Jodi Millicent O'DonnellTracey Joy Weiland
Jun 7, 2018·Frontiers in Behavioral Neuroscience·Barbara WillekensNathalie Cools
Jul 1, 2020·Pilot and Feasibility Studies·Fiona J R EcclesJane Simpson
Jan 22, 2021·Multiple Sclerosis and Related Disorders·Jennifer DunneLucinda J Black
Mar 3, 2021·Journal of Medical Internet Research·Amy-Lee SeselSharon L Naismith
Apr 6, 2021·Physical Medicine and Rehabilitation Clinics of North America·Ileana M Howard, Kathleen Burgess
Apr 21, 2021·Multiple Sclerosis : Clinical and Laboratory Research·Anthony M HarrisonSam Norton

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02364505

Software Mentioned

Skype

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.